Clinical Trial

Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy

Study acronym: 2009-APBI
Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated June 26, 2014 (before its estimated July 2018 completion). Its status may not reflect the trial's current state.
Summary
In the setting of radiotherapy as part of breast-conservation therapy for patients with early stage breast cancer, the novel planning and delivery method of intensity modulated radiotherapy is an effective and safe alternative to the commonly-used standard 3D-conformal external beam radiotherapy, spares more normal breast and lung tissue, and may lead to improved clinical outcomes.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2010-08-18; most recent amendment 2014-06-24.
Trial Details
NCT Number NCT01185132
Lead Sponsor Rocky Mountain Cancer Centers
Conditions Breast Cancer
Enrollment 660 participants
Start Date 2009-07
Primary Completion 2018-07 (estimated)
Study Completion 2028-07 (estimated)
Updated on ClinicalTrials.gov 2014-06-26